Karuna Therapeutics (KRTX) Earnings Per Share (EPS)

Price: $329.83
Market Cap: $12.60B
Avg Volume: 971.83K
Country: US
Industry: Biotechnology
Sector: Healthcare
Beta: 1.149
52W Range: $158.375-329.99
Website: Karuna Therapeutics
Earnings Per Share (EPS) Summary (Annual)

According to Karuna Therapeutics's latest annual financial reports, the company has an earnings per share (EPS) of $-11.73 and a diluted EPS of $-11.73. The EPS indicates the portion of a company's profit allocated to each outstanding share of common stock, serving as an indicator of a company's profitability.

The company's EPS growth rate stands at -34.21%, and the diluted EPS growth rate is -34.21%. These metrics reflect the annual growth rate of earnings per share and diluted earnings per share over the specified period.

EPS

$-11.73

Diluted EPS

$-11.73

EPS Growth

-34.21%

Karuna Therapeutics Historical EPS
$0.00$0.00$-3.00$-3.00$-6.00$-6.00$-9.00$-9.00$-12.00$-12.00EPS201820182019201920202020202120212022202220232023
Karuna Therapeutics Historical EPS Growth
53.38%53.38%-8.72%-8.72%-70.82%-70.82%-132.92%-132.92%EPS Growth201820182019201920202020202120212022202220232023
EPS History

The table below shows the EPS for each year, with the latest data available for the last fiscal year 2023.

Year EPS Change
2023 $-11.73 -34.21%
2022 $-8.74 -76.92%
2021 $-4.94 -90.73%
2020 $-2.59 30.93%
2019 $-3.75 -132.92%
2018 $-1.61 -98.77%
2017 $-0.81 0.00%

Related Metrics

Explore detailed financial metrics and analysis for KRTX.

Financial Analysis
Financial Statements Stock Forecast Price Target Technical Analysis Stock Splits Employee Count
Company Intelligence
Ownership Insider Trading SEC Filings Congress Trading News Earnings Call Transcripts
Income & Revenue
Earnings Revenue Revenue Growth Profit Net Income Profit Margin EBITDA Free Cash Flow Revenue Segments
Valuation
Valuation Market Cap Enterprise Value P/E Ratio PEG Ratio P/S Ratio P/B Ratio Book Value
Returns & Ratios
ROIC ROE ROA Current Ratio Quick Ratio Debt/Equity Ratio Earnings Per Share
Balance Sheet
Assets Debt Cash On Hand Shares Outstanding
Dividends
Dividends Dividend Yield Payout Ratio